Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — PATH

Balance Sheet

(in billions USD)

Metric	Q2 2027	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	0.61	0.63	0.87	0.74	0.63	0.70	0.88	0.77	0.94	1.15	1.06	1.00	1.09	1.31	1.40	1.45	1.61	1.68	1.77	1.78
Short-term Investments	0.68	0.68	0.60	0.65	0.82	0.85	0.75	0.80	0.80	0.79	0.82	0.81	0.74	0.47	0.35	0.23	0.11	0.11	0.10	0.10
Accounts Receivable	0.31	0.30	0.49	0.37	0.27	0.27	0.45	0.34	0.27	0.27	0.44	0.37	0.23	0.23	0.37	0.28	0.19	0.17	0.25	0.20
Total Current Assets	1.93	1.92	2.24	2.09	2.03	2.11	2.34	2.18	2.27	2.47	2.58	2.43	2.30	2.26	2.34	2.16	2.11	2.15	2.28	2.21
Property, Plant & Equipment	0.05	0.05	0.05	0.04	0.04	0.04	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.03	0.03	0.02	0.02	0.01
Goodwill	0.18	0.19	0.13	0.12	0.12	0.12	0.09	0.09	0.09	0.09	0.09	0.09	0.09	0.09	0.09	0.08	0.09	0.05	0.05	0.05
Intangible Assets	0.10	0.10	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.02	0.03	0.02	0.02	0.02
Total Non-current Assets*	0.98	0.99	0.68	0.80	0.56	0.53	0.40	0.49	0.43	0.38	0.37	0.36	0.37	0.39	0.39	0.35	0.33	0.28	0.27	0.26
Total Assets	2.91	2.90	3.18	2.90	2.59	2.64	2.87	2.66	2.70	2.84	2.95	2.79	2.67	2.64	2.74	2.51	2.43	2.42	2.57	2.47
Accounts Payable	0.02	0.02	0.01	0.01	0.02	0.02	0.03	0.02	0.01	0.01	0.00	0.01	0.00	0.01	0.01	0.01	0.01	0.02	0.01	0.02
Total Current Liabilities	0.81	0.83	0.91	0.79	0.74	0.72	0.80	0.70	0.63	0.60	0.71	0.63	0.52	0.50	0.63	0.48	0.46	0.44	0.53	0.47
Total Non-current Liabilities*	0.15	0.17	0.19	0.18	0.19	0.23	0.22	0.24	0.24	0.22	0.23	0.20	0.17	0.18	0.19	0.18	0.13	0.11	0.12	0.12
Total Liabilities	0.96	1.00	1.10	0.97	0.93	0.95	1.02	0.93	0.87	0.82	0.94	0.83	0.69	0.69	0.82	0.65	0.59	0.54	0.65	0.58
Retained Earnings	(1.65)	(1.68)	(1.71)	(1.81)	(2.01)	(2.01)	(1.99)	(2.04)	(2.03)	(1.94)	(1.91)	(1.95)	(1.92)	(1.86)	(1.82)	(1.80)	(1.74)	(1.62)	(1.50)	(1.43)
Total Stockholder Equity	1.95	1.90	2.08	1.92	1.67	1.70	1.85	1.73	1.83	2.03	2.02	1.96	1.98	1.96	1.92	1.86	1.85	1.88	1.92	1.88

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2027	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Total Revenue	410.26	418.38	481.11	411.11	361.73	356.62	423.65	354.65	316.25	335.11	405.25	325.92	287.31	289.59	308.55	262.74	242.22	245.07	289.70	220.82
Cost of Revenue	80.59	76.93	73.94	68.81	64.38	63.86	64.53	63.76	63.32	55.33	53.35	49.92	48.99	43.67	47.69	42.77	44.58	45.02	41.16	43.10
Gross Profit	329.67	341.45	407.17	342.30	297.35	292.77	359.11	290.89	252.93	279.79	351.90	276.00	238.32	245.92	260.86	219.98	197.65	200.05	248.53	177.72
Research & Development	83.39	92.90	95.16	96.87	98.34	94.84	99.67	96.98	98.43	85.60	85.64	84.51	86.61	75.34	81.87	67.34	67.85	68.69	64.41	61.56
Selling, General & Admin	50.07	52.71	53.55	53.18	52.89	54.68	49.00	50.09	63.52	63.51	59.45	56.02	59.58	56.58	50.38	63.16	68.44	57.53	60.24	59.50
Total Operating Expenses	298.07	313.47	326.89	329.23	317.53	309.18	325.50	334.25	356.28	329.25	336.81	331.82	315.91	292.33	306.01	286.97	317.84	316.00	299.41	293.96
Operating Income	31.60	27.99	80.29	13.07	(20.18)	(16.41)	33.61	(43.36)	(103.35)	(49.46)	15.10	(55.82)	(77.58)	(46.41)	(45.15)	(66.99)	(120.19)	(115.95)	(50.88)	(116.25)
Pretax Income	52.86	40.97	92.44	24.59	3.33	(19.73)	54.62	(25.50)	(82.27)	(24.96)	36.60	(27.61)	(56.53)	(28.27)	(26.96)	(56.54)	(116.29)	(117.77)	(54.68)	(119.65)
Tax Provision	16.77	18.44	(12.02)	(174.25)	1.74	2.83	2.83	(14.84)	3.83	3.78	2.68	3.93	3.83	3.63	0.73	1.18	4.09	4.79	8.43	3.14
Net Income	36.09	22.53	104.46	198.84	1.58	(22.55)	51.79	(10.65)	(86.10)	(28.74)	33.92	(31.54)	(60.36)	(31.90)	(27.69)	(57.72)	(120.38)	(122.56)	(63.11)	(122.79)
Basic EPS	0.07	0.04	0.19	0.37	0.00	(0.04)	0.09	(0.02)	(0.15)	(0.05)	0.07	(0.06)	(0.11)	(0.06)	(0.05)	(0.10)	(0.22)	(0.23)	(0.08)	(0.23)
Diluted EPS	0.07	0.04	0.19	0.37	0.00	(0.04)	0.09	(0.02)	(0.15)	(0.05)	0.07	(0.06)	(0.11)	(0.06)	(0.05)	(0.10)	(0.22)	(0.23)	(0.08)	(0.23)

← Scroll for more columns →

Cash Flow Statement

(in millions USD)

Metric	Q2 2027	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Cash Flow	30.70	131.93	182.35	28.27	41.59	119.00	146.08	28.07	46.38	100.04	145.60	41.85	44.29	67.34	93.96	(27.32)	(23.74)	(52.88)	(6.01)	(25.43)
Capital Expenditures	1.39	2.68	3.05	3.16	0.00	12.83	7.39	4.88	1.42	1.24	3.78	0.68	1.01	1.87	2.20	5.32	6.61	9.69	3.16	2.08
Free Cash Flow*	29.31	129.24	179.30	25.11	41.59	106.17	138.69	23.20	44.96	98.80	141.82	41.17	43.28	65.47	91.76	(32.63)	(30.34)	(62.58)	(9.17)	(27.50)
Investing Cash Flow	(15.72)	(112.84)	(42.65)	100.76	(0.65)	(79.92)	(16.70)	(22.91)	(41.66)	35.77	(8.64)	(60.25)	(235.12)	(135.55)	(126.47)	(118.23)	(28.75)	(15.70)	(6.32)	(51.04)
Financing Cash Flow	(34.93)	(252.19)	(14.40)	(11.17)	(111.60)	(235.20)	(16.98)	(172.64)	(215.15)	(45.74)	(81.92)	(69.15)	(25.20)	(20.63)	(16.87)	(6.64)	(18.97)	(18.19)	(2.37)	20.09

← Scroll for more columns →

* Derived from reported values